| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |